Ceftaroline Activity Tested Against Pathogens Associated With Acute Bacterial Skin and Skin-Structure Infections (ABSSSI) Isolated From Latin American Medical Centers (2010)

Background: Ceftaroline is a new cephalosporin with activity against Gram-positive cocci, including methicillin-resistant S. aureus (MRSA) and Enterobacteriaceae species. The prodrug, ceftaroline fosamil is approved by the USA-FDA for treatment of ABSSSI.